ESMO20 YO for YO: highlights on metastatic renal cell carcinoma—the CheckMate-9ER trial

por Kfoury, M., Oing, C.
Publicado 2021

Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy

por Oing, C., Bristow, R.G.
Publicado 2023

Involvement of ATM in homologous recombination after end resection and RAD51 nucleofilament formation

por Bakr, A., Oing, C., Köcher, S., Borgmann, K., Dornreiter, I., Petersen, C., Dikomey, E., Mansour, W.Y.
Publicado 2015

Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry

por Fichtner, A., Bohnenberger, H., Elakad, O., Richter, A., Lenz, C., Oing, C., Ströbel, P., Kueffer, S., Nettersheim, D., Bremmer, F.
Publicado 2022

Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer

por Mansour, W. Y., Tennstedt, P., Volquardsen, J., Oing, C., Kluth, M., Hube-Magg, C., Borgmann, K., Simon, R., Petersen, C., Dikomey, E., Rothkamm, K.
Publicado 2018

The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration

por Banerjee, S., Lim, K.H.J., Murali, K., Kamposioras, K., Punie, K., Oing, C., O'Connor, M., Thorne, E., Devnani, B., Lambertini, M., Westphalen, C.B., Garrido, P., Amaral, T., Morgan, G., Haanen, J.B.A.G., Hardy, C.
Publicado 2021

The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II

por Lim, K.H.J., Murali, K., Kamposioras, K., Punie, K., Oing, C., O’Connor, M., Thorne, E., Amaral, T., Garrido, P., Lambertini, M., Devnani, B., Westphalen, C.B., Morgan, G., Haanen, J.B.A.G., Hardy, C., Banerjee, S.
Publicado 2021

The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series

por Lim, K.H.J., Murali, K., Thorne, E., Punie, K., Kamposioras, K., Oing, C., O’Connor, M., Élez, E., Amaral, T., Garrido, P., Lambertini, M., Devnani, B., Westphalen, C.B., Morgan, G., Haanen, J.B.A.G., Hardy, C., Banerjee, S.
Publicado 2021

LBA70_PR The impact of COVID-19 on oncology professionals: Initial results of the ESMO resilience task force survey collaboration

por Banerjee, S., Lim, K.H.J., Kamposioras, K.V., Murali, K., Oing, C., Punie, K., O'Connor, M., Devnani, B., Lambertini, M., Benedikt Westphalen, C., Garrido Lopez, P., Amaral, T.M.S., Thorne, E., Morgan, G., Haanen, J.B.A.G., Hardy, C.
Publicado 2020

1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series

por Lim, K.H.J., Punie, K., Oing, C., Thorne, E., Murali, K., Kamposioras, K.V., O'Connor, M., Elez, E., Amaral, T.M.S., Lopez, P. Garrido, Lambertini, M., Devnani, B., Westphalen, C.B., Morgan, G., Haanen, J.B.A.G., Hardy, C., Banerjee, S.
Publicado 2021

Young oncologists’ perspective on the role and future of the clinician-scientist in oncology

por Lim, K.H.J., Westphalen, C.B., Berghoff, A.S., Cardone, C., Connolly, E.A., Güven, D.C., Kfoury, M., Kocakavuk, E., Mandó, P., Mariamidze, E., Matikas, A., Moutafi, M., Oing, C., Pihlak, R., Punie, K., Sánchez-Bayona, R., Sobczuk, P., Starzer, A.M., Tečić Vuger, A., Zhu, H., Cruz-Ordinario, M.V.B., Altuna, S.C., Canário, R., Vuylsteke, P., Banerjee, S., de Azambuja, E., Cervantes, A., Lambertini, M., Mateo, J., Amaral, T.
Publicado 2023